RIL
CTKB icon

Rothschild Investment LLC’s Cytek Biosciences CTKB Stock Holding History

Rothschild Investment LLC’s Portfolio CTKB Stock Details CTKB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.32K Sell
299
-95
-24% -$406 ﹤0.01% 2933
2026
Q1 		$1.72K Buy
394
+118
+43% +$557 ﹤0.01% 2623
2025
Q4 		$1.39K Buy
276
+11
+4% +$51 ﹤0.01% 2545
2025
Q3 		$920 Buy
265
+115
+77% +$432 ﹤0.01% 2621
2025
Q2 		$510 Sell
150
-75
-33% -$250 ﹤0.01% 2740
2025
Q1 		$902 Buy
225
+80
+55% +$415 ﹤0.01% 2400
2024
Q4 		$941 Buy
145
+75
+107% +$447 ﹤0.01% 2252
2024
Q3 		$388 Buy
70
+30
+75% +$170 ﹤0.01% 2543
2024
Q2 		$223 Buy
40
+20
+100% +$120 ﹤0.01% 2454
2024
Q1 		$134 Buy
+20
New +$158 ﹤0.01% 1994

Other funds holding CTKB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $386M AUM 2.37% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Rothschild Investment LLC's CTKB Position: Q2 2026 in Review

Rothschild Investment LLC reduced its Cytek Biosciences (CTKB) stake by 24% in Q2 2026, selling an estimated $406 and leaving 299 shares worth $1.32K. The position accounts for ﹤0.01% of the portfolio, ranked #2933.

Rothschild Investment LLC first reported a position in CTKB in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.72K in Q1 2026. 154 funds tracked by Wall St. Rank hold CTKB as of Q2 2026.

  • Rothschild Investment LLC held 299 shares of Cytek Biosciences worth $1.32K as of Q2 2026.
  • Rothschild Investment LLC sold 95 Cytek Biosciences shares in Q2 2026, an estimated $406.
  • Cytek Biosciences made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2933 holding.
  • Rothschild Investment LLC first reported a position in Cytek Biosciences in Q1 2024 and has held it in 10 quarters since.
  • Rothschild Investment LLC's Cytek Biosciences position peaked at $1.72K in Q1 2026.
  • 154 funds tracked by Wall St. Rank held Cytek Biosciences as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.